A review of 26 RCTs (n = 1536) showed that supplementation with probiotics/symbiotics is associated with a tendency to increase adiponectin levels, particularly in patients with type 2 diabetes, metabolic syndrome, and prediabetes [182]. Here, ADIPOQ is linked to metabolic syndrome.